Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis

被引:8
|
作者
Xu, Tai [1 ,2 ]
Zhang, Siming [1 ]
Qiu, Dongqin [1 ]
Li, Xiaoyuan [1 ]
Fan, Yuanlin [1 ]
机构
[1] Meizhou Peoples Hosp, Dept Breast Surg, 63 Huangtang Rd, Meizhou 514000, Guangdong, Peoples R China
[2] Meizhou Peoples Hosp, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou 514000, Guangdong, Peoples R China
关键词
Breast cancer; Matrix metalloproteinase 9; Polymorphism; Meta-analysis; MATRIX METALLOPROTEINASES; GENETIC POLYMORPHISMS; PROMOTER REGIONS; GELATINASE-B; MMP-9; STATISTICS; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;
D O I
10.1016/j.gene.2020.144972
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have sought associations between matrix metalloproteinase 9 (MMP-9) polymorphisms and breast cancer risk. However, these studies have yielded conflicting results. Hence, we performed an updated meta-analysis to clarify the effects of four MMP-9 gene polymorphisms (rs3918242, rs2250889, rs3787268, and rs17576) on breast cancer risk. Methods: A comprehensive literature search for eligible studies was conducted in five electronic databases, including PubMed, Embase and Web of Science, up to March 1, 2020. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations in random-effects models. For the reduction of type I errors, a trial sequential analysis (TSA) was performed. Results: Twenty-one studies (8813 breast cancer cases and 9323 controls) were included in the quantitative analysis. For rs3918242, the overall ORs were significant under allelic comparison (OR (A vs. G) = 1.34; 95% CI 1.03, 1.74, P = 0.028) and the recessive genetic model (OR (AA vs. GG+GA) = 1.40; 95% CI 1.06, 1.84, P = 0.016). For rs2250889, the ORs were significant under homozygote comparison (OR (GG vs. CC) = 2.57; 95% CI 1.22, 5.42, P = 0.013), heterozygote comparison (OR (GC vs. CC) = 2.48; 95% CI 1.17, 5.23, P = 0.018), and the dominant genetic model (OR (GG+GC vs. CC) = 2.53; 95% CI 1.23, 5.20, P = 0.012). No associations were observed for rs3787268 or rs17576. The subgroup analyses indicated that the risk effect of the rs3918242 A allele was observed only among Asians. TSA showed that the findings for rs3918242, rs3787268, and rs17576 were robust, but many more patients are needed before definitive conclusions can be made for rs2250889. Conclusion: Our meta-analysis suggests that MMP-9 rs3918242, but not rs3787268 and rs17576 polymorphisms, may be risk factors for breast cancer. The effect of rs2250889 needs further confirmation with a larger sample size.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis
    Qin, Zhiqiang
    Tang, Jingyuan
    Li, Xiao
    Yu, Yajie
    Zhang, Chuanjie
    Han, Peng
    Li, Ran
    Jiang, Xuping
    Yang, Chengdi
    Wang, Wei
    Tang, Min
    Zhang, Wei
    [J]. ONCOTARGET, 2017, 8 (31) : 51766 - 51778
  • [2] The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis
    Peng, Ziheng
    Jia, Jinhai
    Gong, Wenjian
    Gao, Xuehan
    Ma, Peiru
    Jin, Zhucheng
    Fan, Yue
    Li, Yanchu
    Zhang, Xiaolin
    [J]. ONCOTARGET, 2017, 8 (58) : 99024 - 99032
  • [3] Association between the HOTAIR polymorphisms and cancer risk: an updated meta-analysis
    Zhang, Zhao-Xiong
    Tong, Xue
    Zhang, Wan-Ni
    Fu, Wei-Neng
    [J]. ONCOTARGET, 2017, 8 (03) : 4460 - 4470
  • [4] Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis
    Zou, Fenfang
    Zhang, Jianpeng
    Xiang, Guoan
    Jiao, Hongbin
    Gao, Hongmei
    [J]. CANADIAN RESPIRATORY JOURNAL, 2019, 2019
  • [5] Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
    Zhao, Lin
    Yin, Xiang-Xiongyi
    Qin, Jun
    Wang, Wei
    He, Xiao-Feng
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [6] Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review
    Zhou, Hongxing
    Zhu, Xuming
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5247 - 5259
  • [7] Association between Four MMP-9 Polymorphisms and Breast Cancer Risk: A Meta-Analysis
    Zhang, Xiaoli
    Jin, Guoyin
    Li, Jianfeng
    Zhang, Linxi
    [J]. MEDICAL SCIENCE MONITOR, 2015, 21 : 1115 - 1123
  • [8] Association Between Matrix Metalloproteinase-1, 2, 3 Polymorphisms and Oral Cancer Risk: A Meta-Analysis
    Li, Yingcai
    Wang, Yuqian
    Sun, Hongyan
    Zhang, Yan
    Li, Hui
    Cong, Xianling
    Yin, Wanzhong
    Song, Wenzhi
    [J]. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (08) : 456 - 464
  • [9] Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis
    Xin, Lingli
    Hou, Qingxiang
    Xiong, Qi
    Ding, Xiaoping
    [J]. BIOMEDICAL REPORTS, 2015, 3 (04) : 559 - 565
  • [10] Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk
    Peng, Bo
    Cao, Lihuan
    Ma, Xiaopin
    Wang, Wenzhang
    Wang, Dan
    Yu, Long
    [J]. MUTAGENESIS, 2010, 25 (04) : 371 - 379